Global In Silico Clinical Trial Market

$2,850.00

产品代码: GH03934R 行业: 地区:

In silico clinical trials refers to the development of patient-specific models to form virtual cohorts for testing the safety and efficacy of new drugs and of new medical devices. 而且, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and advise clinical decisions. A chief advantage of in silico clinical trials is the substantial cost savings. The market for in silico clinical trial worldwide is expected to reach USD 4,536 百万 2029, 复合年增长率为 7.5% 根据 Gen Consulting 公司的最新报告,预测期内.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global in silico clinical trial market. 它提供了对市场的定量分析,使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the therapeutic area, phase, 行业, 和地区. The global market for in silico clinical trial can be segmented by therapeutic area: cardiology, 糖尿病, 传染性疾病, 神经病学, 肿瘤学, 其他的. The oncology segment is estimated to account for the largest share of the global in silico clinical trial market. In silico clinical trial market is further segmented by phase: 第一阶段, 第二阶段, 第三阶段, 第四阶段. The phase II segment held the largest revenue share in 2022. Based on industry, the in silico clinical trial market is segmented into: 医疗设备, 药品. 全球范围, the medical devices segment made up the largest share of the in silico clinical trial market. 根据地区, the in silico clinical trial market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. North America was the largest contributor to the global in silico clinical trial market in 2022.

市场细分
By therapeutic area: cardiology, 糖尿病, 传染性疾病, 神经病学, 肿瘤学, 其他的
By phase: 第一阶段, 第二阶段, 第三阶段, 第四阶段
By industry: 医疗设备, 药品
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report has also analysed the competitive landscape of the global in silico clinical trial market with some of the key players being Abzena Limited, Aganitha AI Inc., Certara, 公司, Codexis Inc., 创意生物实验室, 公司, Dassault Systems是, Evotec SE, GNS Healthcare Inc ., Immunetrics Inc., Insilico Biotechnology AG (横河电机株式会社), Insilico Medicine Inc., InSilicoTrials Technologies SpA, Instem plc (LeadScope, 公司), Novadiscovery SAS, 西门子公司, ZMT Zurich MedTech AG, 除其他外. 在这份报告中, 全面分析关键参与者及其策略,以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global in silico clinical trial market.
• To classify and forecast the global in silico clinical trial market based on therapeutic area, phase, 行业, 地区.
• To identify drivers and challenges for the global in silico clinical trial market.
• 检查竞争性发展,例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global in silico clinical trial market.
• To identify and analyze the profile of leading players operating in the global in silico clinical trial market.

为什么选择这份报告
• Gain a reliable outlook of the global in silico clinical trial market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.

Global In Silico Clinical Trial Market

对这份报告感兴趣? 立即获取免费样品!
Global In Silico Clinical Trial Market - 报告范围
报告属性

细节

基准年

2022

预测年份

2023-2029

复合年增长率 (2023-2029)

7.49%

页数

89

行业参与者

Abzena Limited, Aganitha AI Inc., Certara Inc., Codexis Inc., 创意生物实验室公司, Dassault Systems是, Evotec SE, GNS Healthcare Inc ., Immunetrics Inc., Insilico Biotechnology AG (横河电机株式会社), Insilico Medicine Inc., InSilicoTrials Technologies SpA, Instem plc (LeadScope Inc.), Novadiscovery SAS, 西门子公司, ZMT Zurich MedTech AG

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global In Silico Clinical Trial Market

请填写我们的表格,我们会尽快回复您.